AONC
American Oncology Network, Inc. Class A Common Stock
AONC
AONC
Delisted
AONC was delisted on the 7th of June, 2024.
6 hedge funds and large institutions have $348K invested in American Oncology Network, Inc. Class A Common Stock in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
2
JPMorgan Chase & Co
New York
|
$12 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AC
1
Applied Capital
Little Rock,
Arkansas
| $221K | 37,499 | +37,499 | New |
|
2
Geode Capital Management
Boston,
Massachusetts
| $127K | 22,058 | +9,683 | +78% |
|
3
Wells Fargo
San Francisco,
California
| $65 | 11 | +11 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $18 | 3 | +3 | New |
|
|
5
JPMorgan Chase & Co
New York
| $12 | 2 | -321 | -99% |
|
|
6
UBS Group
Zurich,
Switzerland
| – | – | -2,540 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
8
Barclays
London,
United Kingdom
| $0 | 38 | +38 | New |
|